Douglas MurphyChutorian - Semler Scientific President CEO, Director

SMLR Stock  USD 27.09  0.83  3.16%   

CEO

Dr. Douglas MurphyChutorian, M.D. is a President, Chief Executive Officer, Director of Semler Scientific, Inc. He has served as a member of our board of directors since September 2012 and as our chief executive officer since October 31, 2012. Dr. MurphyChutorian has had broad, diverse career experience in healthcare over the past 30 years, stretching from clinician, academician, inventor, entrepreneur, chief executive officer, chairman of the board, and consultant to financial firms. Since April 15, 2005, he was managing director of Select Healthcare Capital, LLC. Dr. MurphyChutorian is a named inventor on more than 30 patents, and has guided more than 50 products through various regulatory approval processes. His business career has included extensive involvement in all facets of the medical industry from financial, research and development, manufacturing, marketing and sales, regulatory, reimbursement, and clinical trials. His breadth of healthcare experience includes all major sectors of the industry medical devices, health services, pharmaceuticals, biotechnology and managed care. He received his B.A. and M.D. from Columbia University. He completed his internal medicine residency at New York UniversityBellevue Medical Center and his fellowship in cardiology at Stanford University Medical Center. He has served as a faculty member in interventional cardiology at both Stanford and Montefiore Medical Center. Dr. MurphyChutorians experience as a cardiologist, inventor and executive, in particular serving as our Chief Executive Officer, qualify him to be a director of our company. since 2016.
Age 62
Tenure 8 years
Address 2340-2348 Walsh Avenue, Santa Clara, CA, United States, 95051
Phone(877) 774-4211
Webhttps://www.semlerscientific.com
MurphyChutorian is a named inventor on more than 30 patents, and has guided more than 50 products through various regulatory approval processes. His business career has included extensive involvement in all facets of the medical industry from financial, research and development, manufacturing, marketing and sales, regulatory, reimbursement, and clinical trials. His breadth of healthcare experience includes all major sectors of the industry: medical devices, health services, pharmaceuticals, biotechnology and managed care. He received his B.A. and M.D. from Columbia University. He completed his Internal Medicine residency at New York University/Bellevue Medical Center and his fellowship in Cardiology at Stanford University Medical Center.

Semler Scientific Management Efficiency

The company has return on total asset (ROA) of 0.2042 % which means that it generated a profit of $0.2042 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.3229 %, meaning that it created $0.3229 on every $100 dollars invested by stockholders. Semler Scientific's management efficiency ratios could be used to measure how well Semler Scientific manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Semler Scientific's Return On Tangible Assets are relatively stable compared to the past year. As of 04/24/2024, Return On Assets is likely to grow to 0.28, while Return On Capital Employed is likely to drop 0.29. At this time, Semler Scientific's Intangibles To Total Assets are relatively stable compared to the past year. As of 04/24/2024, Fixed Asset Turnover is likely to grow to 23.82, while Other Assets are likely to drop 0.95.
The company currently holds 70 K in liabilities with Debt to Equity (D/E) ratio of 0.01, which may suggest the company is not taking enough advantage from borrowing. Semler Scientific has a current ratio of 7.09, suggesting that it is liquid enough and is able to pay its financial obligations when due. Debt can assist Semler Scientific until it has trouble settling it off, either with new capital or with free cash flow. So, Semler Scientific's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Semler Scientific sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Semler to invest in growth at high rates of return. When we think about Semler Scientific's use of debt, we should always consider it together with cash and equity.

Similar Executives

Found 4 records

CEO Age

Jon KesslerHealthEquity
56
Michael HaysNational Research Corp
69
Oivind HorpestadNational Research Corp
N/A
Lennart FlemNational Research Corp
N/A
Semler Scientific, Inc. provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers in the United States. Semler Scientific, Inc. was incorporated in 2007 and is headquartered in Santa Clara, California. Semler Scientific operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 124 people. Semler Scientific (SMLR) is traded on NASDAQ Exchange in USA. It is located in 2340-2348 Walsh Avenue, Santa Clara, CA, United States, 95051 and employs 92 people. Semler Scientific is listed under Health Care Equipment & Supplies category by Fama And French industry classification.

Management Performance

Semler Scientific Leadership Team

Elected by the shareholders, the Semler Scientific's board of directors comprises two types of representatives: Semler Scientific inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Semler. The board's role is to monitor Semler Scientific's management team and ensure that shareholders' interests are well served. Semler Scientific's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Semler Scientific's outside directors are responsible for providing unbiased perspectives on the board's policies.
Dennis Rosenberg, Chief Officer
Aidan Collins, Director
Arthur Leibowitz, Director
Chutorian Murphy, CEO, Director
Herbert Semler, Chairman of the Board, Co-Founder
Andrew Weinstein, Principal Financial Officer, Senior Vice President - Finance and Accounting
James Walker, CFO
Douglas MD, President CEO
Cindy Guinasso, Senior Development
Robert McRae, Chief Officer
Bruce Barclay, Director
Jennifer Herrington, Chief Officer
Shirley Semler, Co-Founder, Director
Douglas MurphyChutorian, President CEO, Director
Shane Reid, Chief Officer
Wayne Pan, Director
Greg Garfield, Director
Daniel Conger, VP of Fin.
Renae Cormier, Principal CFO

Semler Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Semler Scientific a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Currently Active Assets on Macroaxis

When determining whether Semler Scientific is a strong investment it is important to analyze Semler Scientific's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Semler Scientific's future performance. For an informed investment choice regarding Semler Stock, refer to the following important reports:
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Semler Scientific. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis.
To learn how to invest in Semler Stock, please use our How to Invest in Semler Scientific guide.
You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.

Complementary Tools for Semler Stock analysis

When running Semler Scientific's price analysis, check to measure Semler Scientific's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Semler Scientific is operating at the current time. Most of Semler Scientific's value examination focuses on studying past and present price action to predict the probability of Semler Scientific's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Semler Scientific's price. Additionally, you may evaluate how the addition of Semler Scientific to your portfolios can decrease your overall portfolio volatility.
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Transaction History
View history of all your transactions and understand their impact on performance
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Equity Valuation
Check real value of public entities based on technical and fundamental data
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Is Semler Scientific's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Semler Scientific. If investors know Semler will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Semler Scientific listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.315
Earnings Share
2.63
Revenue Per Share
10.127
Quarterly Revenue Growth
0.091
Return On Assets
0.2042
The market value of Semler Scientific is measured differently than its book value, which is the value of Semler that is recorded on the company's balance sheet. Investors also form their own opinion of Semler Scientific's value that differs from its market value or its book value, called intrinsic value, which is Semler Scientific's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Semler Scientific's market value can be influenced by many factors that don't directly affect Semler Scientific's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Semler Scientific's value and its price as these two are different measures arrived at by different means. Investors typically determine if Semler Scientific is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Semler Scientific's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.